Company Imagion Biosystems Limited
Equities
IBX
AU000000IBX6
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | -9.76% | -.--% | -79.15% |
Feb. 29 | Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 15 | Imagion Biosystems CEO Resigns | MT |
Business Summary
Sales per Business
AUD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Research & Development
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +103.31% |
Sales per region
AUD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +103.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Geoff Hollis
DFI | Director of Finance/CFO | - | 20-12-07 |
Robert Proulx
CHM | Chairman | 66 | - |
Carmen Soikowski
COO | Chief Operating Officer | - | 21-10-31 |
Marie Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Ludvigson
BRD | Director/Board Member | 74 | 17-03-07 |
Robert Proulx
CHM | Chairman | 66 | - |
Michael Harsh
BRD | Director/Board Member | 69 | 17-02-27 |
Director/Board Member | - | 16-12-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,646,551 | 29,990,272 ( 91.86 %) | 0 | 91.86 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-79.15% | 1.6M | |
-14.68% | 18.88B | |
-42.33% | 2.84B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+27.15% | 1.26B | |
-13.90% | 989M | |
-21.76% | 896M | |
-2.72% | 757M | |
-23.95% | 637M |
- Stock Market
- Equities
- IBX Stock
- Company Imagion Biosystems Limited